Number of the records: 1  

Synthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine

  1. 1.
    SYSNO ASEP0476531
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleSynthesis and antiproteasomal activity of novel O-benzyl salicylamide-based inhibitors built from leucine and phenylalanine
    Author(s) Jorda, Radek (UEB-Q) ORCID, RID
    Dušek, J. (CZ)
    Řezníčková, Eva (UEB-Q) RID, ORCID
    Pauk, K. (CZ)
    Magar, P. P. (CZ)
    Imramovský, A. (CZ)
    Kryštof, Vladimír (UEB-Q) RID, ORCID
    Number of authors7
    Source TitleEuropean Journal of Medicinal Chemistry. - : Elsevier - ISSN 0223-5234
    Roč. 135, JUL 28 (2017), s. 142-158
    Number of pages17 s.
    Languageeng - English
    CountryFR - France
    KeywordsApoptosis ; Inhibitor ; Proteasome ; Salicylamide ; Ubiquitin
    Subject RIVEB - Genetics ; Molecular Biology
    OECD categoryBiochemical research methods
    R&D ProjectsLO1204 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUEB-Q - RVO:61389030
    UT WOS000403512100013
    EID SCOPUS85018470778
    DOI10.1016/j.ejmech.2017.04.027
    AnnotationInhibition of protein degradation is one of strategies for suppression of uncontrolled proliferation of cancer cells. Proteolytic degradation in cells is mainly ensured by proteasome and its inhibition by bortezomib showed benefit in clinical use for the treatment of multiple myeloma. We report here the library of antiproteasomal O-benzyl salicylamides built from leucine and phenylalanine. Prepared compounds displayed antiproliferative activity on K562, CEM and U266 cancer cell lines, ranging from high micromolar to submicromolar GI 50 values. The most potent compounds (series 4 and 6) were further assayed for their inhibition of chymotrypsin-like protease activity of the 26S proteasome in U266 cells. The majority of compounds inhibited the proteasome in mid-nanomolar concentrations (IC 50 ranging from 57 to 197 nM) and it correlated with cellular potency. In a cell based assay involving green fluorescence protein (GFP) fused to a short degron that is rapidly degraded by a proteasome the compounds induced accumulation of GFP, visualised and quantified by live-cell imaging. Levels of polyubiquitinated proteins in U266 cells treated by compound 4m were also analyzed by immunoblotting, revealing a typical high molecular mass smear of ubiquitin conjugates. Finally, apoptotic cell death in treated U266 cells was detected biochemically by measuring the activity of caspases 3 and 7 in lysates and by immunoblotting of caspase 7, its substrate poly(ADP-ribose)polymerase, and Mcl-1, which all together showed changes typical for apoptosis. All these observations were in agreement with expected cellular mechanism of action and confirmed proteasome targeting by prepared O-benzyl salicylamides.
    WorkplaceInstitute of Experimental Botany
    ContactDavid Klier, knihovna@ueb.cas.cz, Tel.: 220 390 469
    Year of Publishing2018
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.